Back
Edge
StocktwitsEarnings
Official STOCKTWITS Representative
symbol logo$EVH Q2 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.25 up 43.18% YoY • Reported revenue of $652.52M up 46.86% YoY • Evolent Health, Inc. is raising its 2026 revenue guidance range to $2.6 billion to $2.7 billion and is tightening its Adjusted EBITDA range to $120 million to $135 million for 2026.
1

Price since post

Full Details

Advertisement|Remove ads.